NVEC

BRACKE JAMES W

Known title: DirectorCIK: 0001265843

BRACKE JAMES W's purchase track record

How the stock did after each of BRACKE JAMES W's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.

Purchases measured
4
of 4 since January 25, 2022
Stock higher 6 months later
50%
3 months: 50%
Median 6-month return
+7.0%
3 months: -1.0%
Beat the S&P 500
25%
median -0.3% vs. index
PurchaseStockAmount3 months6 months
4/4/2025NVEC$6K+30.9%+22.1%
5/9/2022NVEC$5K+17.0%+51.9%
2/4/2022NVEC$6K-19.4%-8.1%
1/25/2022NVEC$18K-19.1%-10.5%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 12, 2026

NVEC reports new medical sensor innovation. A recent Seeking Alpha article highlights NVE Corporation’s introduction of a new medical sensor technology. The development expands the company’s product line and may enhance its long‑term growth prospects. The news is relevant as it could influence future revenue streams and market positioning.

this person other insiders at NVEC

Transaction History

NVEC▲ Buy$6K
NVEC▲ Buy$5K
NVEC▲ Buy$6K
NVEC▲ Buy$18K

We use analytics to understand how market-wall is used. No personal data is sold.